Publication | Closed Access

Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post—Traumatic brain injury

Regenerative MedicineDocosahexaenoic AcidTraumatic Brain InjuryNeuroregenerationTherapeutic PotentialStem Cell ResearchNeuroprotectionStem Cell TherapiesNeuroscienceBrain InjuryNeurologyStem Cell BiologyMedicineNeural Tissue EngineeringNeural Stem CellSocial SciencesBrain Injury Prevention